CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before COVID-19 emerged in 2019 and exploded into global ...

Moderna gets to pocket all of its COVID-19 vaccine revenue, but Pfizer and BioNTech split their profits equally. Perhaps Moderna's omicron booster will ultimately enjoy higher demand than the ...

Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company ...

The messenger RNA (mRNA) approach used by Pfizer, BioNTech, and Moderna, though, appears to hold a key advantage over rival vaccine approaches with its ability to rapidly develop variant-specific ...

Moderna stock is worth ~39% more than BioNTech stock, which is a significant amount, but it has always been the higher valued company, and back in September 2021, it was worth 2x more than BioNTech.

I'm less confident that either will succeed as I once was, so I would be unlikely to invest in either Moderna at current valuation of $58bn, or BioNTech at $38bn, although I would perhaps look to ...

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...